Koninklijke Philips Cost of Goods Sold 2010-2024 | PHG
- Koninklijke Philips cost of goods sold for the quarter ending September 30, 2024 was $2.607B, a 0.74% increase year-over-year.
- Koninklijke Philips cost of goods sold for the twelve months ending September 30, 2024 was $8.005B, a 26.92% decline year-over-year.
- Koninklijke Philips annual cost of goods sold for 2023 was $11.603B, a 3.57% increase from 2022.
- Koninklijke Philips annual cost of goods sold for 2022 was $11.203B, a 5.19% decline from 2021.
- Koninklijke Philips annual cost of goods sold for 2021 was $11.817B, a 3.81% decline from 2020.
Koninklijke Philips Annual Cost of Goods Sold (Millions of US $) |
|
---|---|
2023 | $11,603 |
2022 | $11,203 |
2021 | $11,817 |
2020 | $12,284 |
2019 | $11,880 |
2018 | $11,300 |
2017 | $10,851 |
2016 | $15,386 |
2015 | $15,976 |
2014 | $17,527 |
2013 | $18,119 |
2012 | $19,779 |
2011 | $19,404 |
2010 | $21,079 |
2009 | $21,072 |
Koninklijke Philips Quarterly Cost of Goods Sold (Millions of US $) |
|
---|---|
2024-09-30 | $2,607 |
2024-06-30 | $2,663 |
2023-09-30 | |
2023-06-30 | $2,735 |
2023-03-31 | $2,588 |
2022-06-30 | $2,602 |
2021-06-30 | $2,941 |
2020-06-30 | $2,823 |
2019-06-30 | $2,862 |
2018-06-30 | $2,722 |
2017-06-30 | $2,606 |
2016-12-31 | $4,370 |
2016-09-30 | $3,676 |
2016-06-30 | $3,754 |
2016-03-31 | $3,587 |
2015-12-31 | $4,692 |
2015-09-30 | $3,798 |
2015-06-30 | $3,848 |
2015-03-31 | $3,638 |
2014-12-31 | $4,203 |
2014-09-30 | $4,939 |
2014-06-30 | $4,270 |
2014-03-31 | $4,114 |
2013-12-31 | $5,311 |
2013-09-30 | $4,320 |
2013-06-30 | $4,319 |
2013-03-31 | $4,170 |
2012-12-31 | $5,789 |
2012-09-30 | $4,730 |
2012-06-30 | $4,679 |
2012-03-31 | $4,581 |
2011-12-31 | $5,849 |
2011-09-30 | $4,712 |
2011-06-30 | $4,561 |
2011-03-31 | $4,282 |
2010-12-31 | $6,306 |
2010-09-30 | $4,934 |
2010-06-30 | $4,990 |
2010-03-31 | $4,850 |
2009-12-31 | $5,517 |
2009-09-30 | $5,209 |
2009-06-30 | $5,855 |
2009-03-31 | $4,490 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $24.805B | $19.663B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $204.249B | 26.05 |
Stryker (SYK) | United States | $146.711B | 33.06 |
Boston Scientific (BSX) | United States | $132.644B | 38.14 |
EssilorLuxottica (ESLOY) | France | $112.106B | 0.00 |
Medtronic (MDT) | Ireland | $110.562B | 16.42 |
Haleon (HLN) | United Kingdom | $43.682B | 28.38 |
Lonza Group Ag (LZAGY) | Switzerland | $42.166B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $37.665B | 19.54 |
ResMed (RMD) | United States | $35.786B | 29.41 |
Terumo (TRUMY) | Japan | $29.739B | 0.00 |
Zimmer Biomet Holdings (ZBH) | United States | $21.942B | 13.97 |
Insulet (PODD) | United States | $18.443B | 73.44 |
Baxter (BAX) | United States | $16.957B | 11.03 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
BellRing Brands (BRBR) | United States | $10.158B | 40.72 |
Bio-Rad Laboratories (BIO) | United States | $9.320B | 31.68 |
Demant (WILYY) | Denmark | $8.342B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.294B | 14.62 |
TG Therapeutics (TGTX) | United States | $5.459B | 0.00 |
Haemonetics (HAE) | United States | $4.297B | 20.97 |
Prestige Consumer Healthcare (PBH) | United States | $4.192B | 20.85 |
ICU Medical (ICUI) | United States | $4.125B | 39.27 |
Perrigo (PRGO) | Ireland | $3.830B | 11.27 |
Envista Holdings (NVST) | United States | $3.697B | 27.54 |
Neogen (NEOG) | United States | $3.246B | 37.45 |
Agios Pharmaceuticals (AGIO) | United States | $3.175B | 0.00 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.841B | 18.22 |
QuidelOrtho (QDEL) | United States | $2.700B | 17.38 |
LeMaitre Vascular (LMAT) | United States | $2.428B | 59.00 |
Warby Parker (WRBY) | United States | $2.349B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.913B | 33.48 |
AtriCure (ATRC) | United States | $1.742B | 0.00 |
InMode (INMD) | Israel | $1.597B | 9.61 |
AdaptHealth (AHCO) | United States | $1.326B | 9.48 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.318B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $1.267B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.207B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
Owens & Minor (OMI) | United States | $0.952B | 7.44 |
CeriBell (CBLL) | United States | $0.943B | 0.00 |
National Vision Holdings (EYE) | United States | $0.918B | 30.68 |
Capricor Therapeutics (CAPR) | United States | $0.847B | 0.00 |
Evolus (EOLS) | United States | $0.798B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.684B | 30.25 |
Omeros (OMER) | United States | $0.632B | 0.00 |
Surmodics (SRDX) | United States | $0.563B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.533B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.522B | 0.00 |
Canopy Growth (CGC) | Canada | $0.468B | 0.00 |
Quanterix (QTRX) | United States | $0.451B | 0.00 |
ZimVie (ZIMV) | United States | $0.391B | 32.95 |
Valneva SE (VALN) | France | $0.360B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.341B | 32.41 |
Cerus (CERS) | United States | $0.332B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
Biote (BTMD) | United States | $0.325B | 7.12 |
OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
Zynex (ZYXI) | United States | $0.263B | 55.07 |
Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.225B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.221B | 15.29 |
High Tide (HITI) | Canada | $0.213B | 88.33 |
MacroGenics (MGNX) | United States | $0.203B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
Brainsway (BWAY) | Israel | $0.167B | 100.00 |
Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
Jin Medical (ZJYL) | China | $0.164B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.160B | 0.00 |
FitLife Brands (FTLF) | United States | $0.149B | 18.67 |
TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
Fonar (FONR) | United States | $0.104B | 11.74 |
Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
Veru (VERU) | United States | $0.099B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.40 |
Ayr Wellness (AYRWF) | United States | $0.077B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.073B | 37.50 |
Exagen (XGN) | United States | $0.072B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
InterCure (INCR) | Israel | $0.062B | 0.00 |
Modular Medical (MODD) | United States | $0.058B | 0.00 |
MariMed (MRMD) | United States | $0.057B | 0.00 |
Apyx Medical (APYX) | United States | $0.054B | 0.00 |
Safety Shot (SHOT) | United States | $0.051B | 0.00 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
ImmuCell (ICCC) | United States | $0.033B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 12.83 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |